The National Institute on Drug Abuse (NIDA) has opted not to renew its five-year contract with the University of Mississippi (UM) for cannabis cultivation research, allowing the agreement to expire in 2028. This decision marks a significant shift in the landscape of cannabis research in the United States.
Currently, UM’s contract permits the university to cultivate, process, analyze, store, and distribute cannabis for research purposes, as well as supply cannabis products to the NIDA Drug Supply program. Since the establishment of the contract in 1968, UM has remained the only higher education institution in the country with such authority, and it is one of eight DEA-approved bulk manufacturers and growers.
NIDA’s Statement on Contract Termination
The National Institutes of Health (NIH), which oversees NIDA, issued a statement regarding the contract’s termination. They clarified, “NIH/NIDA’s contract with the University of Mississippi to grow cannabis for research is still in place.” However, the NIH is executing a comprehensive assessment of all existing contracts, aligning with the Executive Order 14222 aimed at enhancing government efficiency.
As part of the HHS cost efficiency initiative, NIH noted that “no new task orders to grow cannabis have been issued.” Nevertheless, the NIDA Drug Supply Program maintains an existing inventory of cannabis products available for research purposes.
Implications for Cannabis Research in Mississippi
The cessation of new task orders raises questions for the future of cannabis research in Mississippi and beyond. Each year, UM receives about $1.5 million from NIDA; the most recent renewal in 2023 included a $2 million work order. Jacob Batte, the university’s director of news and media relations, expressed the institution’s readiness to utilize its 57 years of cannabis research experience to support NIDA’s future needs.
UM also emphasized its ongoing commitment to cannabis research through its School of Pharmacy, which plays a significant role in cannabis discovery and innovation via the National Center for Natural Products Research and the Resource Center for Cannabis and Cannabinoid Research.
As the cannabis industry evolves, particularly in Mississippi, the implications of NIDA’s decision could shape opportunities for research and development in this growing sector.